Leaders of Tomorrow
Leaders of Tomorrow
MOMENTUM PICK
ICICI Securities – Retail Equity Research
February 17, 2021 ICICI Securities Ltd. | Retail Equity Research 1
Biggest risk in today’s market is not being there in the market
MOMENTUM PICK
Nifty 50
Nifty 50thorugh
throughthe years
the years
16000 US China
trade war
Covid
crash
14000
Slowdown in
China, Demonetisation
12000 devaluation of
Yuan
10000 Change in
Downgrade in Indian
US credit Government
ratings
8000 Subprime
crisis
4000
2000
MOMENTUM PICK
Nifty currently trades at a PE of ~32x (based on FY20 EPS) and at a PE of Trend in Sectoral Weightages in Nifty
~38x on Trailing Twelve Months (TTM) basis, thereby helping build the public
Sectors/Year Mar-09 Mar-14 Mar-19 Dec-20
opinion that the broader markets are highly euphoric and running ahead of
Financial Services 11.8 27.5 38.9 38.8
fundamentals. We however dispel this notion, as we logically derive that
present absolute PE multiples make little sense especially when we had a blip IT 9.1 16.3 13.7 16.3
in corporate earnings in the recent past due to the Covid pandemic and are Oil & Gas 40.7 14.3 15.3 12.5
staging an impressive earnings CAGR (24%+ over FY21-23E) ahead of us. FMCG 6.4 12.6 11.3 11.5
Automobile 3.3 8.8 6.1 5.4
Our key focal points: Pharmaceuticals 2.5 5.2 2.4 3.6
Metals 5.4 4.8 3.7 2.5
(i) Nifty constituents have undergone major change in past decade. The Telecom 9.8 1.7 1.5 2.0
weights of capital efficient sectors such as FMCG, Financials (private
banks), IT and Pharma have increased from 29% in March 2009 to 70% in
December 2020.
Target PE of few individual constituents based on FY23EPS
MOMENTUM PICK
March -61973 80
April -6884 8400
May 14569 60
June 21832 6400
July 7563 40
4400
August 47080
September -7783 20 2400
October 19541
0 400
November 60358
December 62016
January (till
23630 Greater than 90% of the NSE500
26th Jan 2021)
FII Inflow s/Outflow s stocks are trading above their 200
2020 170262
SMA. This has never happened in
2019 101122 previous bull runs. This highlights
broad based participation and
Interest rates at all time low Asset quality concerns peaked out
10
India 10 Year G-Sec Yield %
MOMENTUM PICK
9
12 10.8
10.3
8 10 9.0
8.5 8.5
7.6 7.8
8
7
(%)
(%)
6
4.6
6 3.8
4 3.1 3.2
2.2 2.3 2.6 2.5
5 2
4 0
Sep-20
Sep-20
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Mar-19
Mar-20
Nov-2011
Aug-2014
Nov-2014
Aug-2017
Aug-2019
Mar-2018
Mar-2020
Apr-2011
Apr-2013
Sep-2015
Apr-2016
Dec-2010
Dec-2015
Dec-2017
Dec-2019
Feb-2012
Feb-2015
Feb-2017
Jun-2018
Jun-2015
Jan-2013
Jan-2014
Jan-2019
Jul-2011
Jul-2016
Oct-2016
Oct-2018
May-2012
Jul-2012
Oct-2012
Jul-2013
Oct-2013
May-2014
May-2017
May-2019
Jul-2020
Oct-2020
Corporate debt at lowest levels
%
39.5 5.5
40 4.2
5.0
36.6
(%)
35 33.5 -
32.0
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
29.9
30 (5.0)
Nov-12
Nov-13
Nov-14
Nov-15
Nov-17
Nov-18
Nov-20
Nov-11
Nov-16
Nov-19
MOMENTUM PICK
Steady demand from core industries should improve capacity utilisation in steel sector Focus on infrastructure to provide headroom for cap utilisation levels in cement sector
450% 392%
400% 360% Performance between 2009-2015
Broader Indices 1 year 3 year 5 year 10 year
350%
MOMENTUM PICK
Nifty 50 16.6% 26.3% 86.0% 155.3% 300% 277% 266%
231%
Nifty 100 16.1% 23.2% 85.1% 161.9% 250% 210%
189% 178% 173%
200%
Nifty midcap 100 16.4% -0.2% 69.5% 168.0% 150%
100% 77%
Nifty smallcap 100 14.8% -19.9% 44.1% 101.8% 44%
50% 16%
0%
-50%
-34%
-100%
NSEINFR Index
NSEPHRM Index
NSEFIN Index
NSEBANK Index
NSEMCAP Index
Nifty Index
SENSEX Index
NSEIT Index
NSESMCP Index
NSEMET Index
NSEREAL Index
NSE100 Index
NSENRG Index
NSEMCAP
NSEINFR Index
NSESMCP
NSEFIN Index
Nifty Index
NSEBANK Index
SENSEX Index
NSEMET Index
NSEIT Index
NSEREAL Index
NSEPHRM
NSE100 Index
NSENRG Index
Index
Index
Index
Source: Bloomberg, ICICI Direct Research
February 17, 2021 ICICI Securities Ltd. | Retail Equity Research 7
Favorable government policies
MOMENTUM PICK
Capex plan under National Infrastructure plan PLI scheme boost for favorable domestic manufacturing
13.2
15 4.2 Manufacturing of Medical devices 3420
4.6 4.0 3.6
4.4 4.7 1.9
9.0 Advanced Cell Chemistry Battery 18100
10 2.3 2.2 1.6
2.6 3.1 2.7 1.7
3.0 3.3 2.2 Electronic/Technology products 5000
1.3 3.8 1.7 3.6 2.5 2.4 3.3
5
3.3 Automobiles & Auto Components 57042
4.4 3.0 4.4 4.7 5.0 4.7 Pharmaceutical Drugs 15000
Renewable capacity
MOMENTUM PICK
1,000 917
Advancements in battery technology & scale 95000 91153
benefits through higher EV adotion has driven 89229
800 721 90000 87027
663 battery costs lower globally
588 85000
600
US$/kWh
2012
2014
2015
2016
2017
2018
2013
2019
2020
55000
Li-ion battery costs
50000
2018 2019 2020 Sep-20 Dec-20
40.0
30.0
Small-caps are essentially the companies which rank 251 and beyond in the pegging order of listed companies on market capitalization basis.
MOMENTUM PICK
Participation
across the
value chain
Opportunities
Large Caps – Top 100 companies by for industries
market cap
(As of Dec 2020: MCap ~>=₹ 29,000
crore) Economic
growth Growth opportunities spur new
winners on an ongoing basis …
MOMENTUM PICK
Leader with 43% market
share grows to 50% market Implied profit
share in next 5 years 1.9x multiplication = >2x
Industry today’s size
growing at
10% CAGR
1.6x present
size in next 5 Smaller player with 11%
years market share grows to 15% Implied profit
Implied profit
market share in 5 years multiplication
multiplication = >2.5x
= >2.5x
2.2x today’s size
While large cap index and mid cap index have rescaled previous peak (as of January 2021), small cap index remains well below its life high (~23% from
top) signalling that previous peak is still some distance away …
MOMENTUM PICK
25,000
Attained a new peak
20,000
15,000
Index value
10,000
Jan-11
Jan-12
Jan-13
Jan-14
Jan-15
Jan-16
Jan-17
Jan-18
Jan-19
Jan-21
Jan-09
Jan-10
Jan-20
Jul-08
Jul-09
Jul-10
Jul-11
Jul-12
Jul-13
Jul-14
Jul-15
Jul-16
Jul-17
Jul-18
Jul-19
Jul-20
Nifty 50 Nifty MidCap 100 Nifty SmallCap 100
Nifty 50 Nifty Midcap 100 Nifty Small Cap 100 Small Cap Alpha (% )
CY Year end index YoY Returns Year end YoY Returns Year end YoY Returns Over Nifty
MOMENTUM PICK
Over Nifty
value (% ) index value (% ) index value (% ) Midcap
• Historically, small caps have bounced
2020 13,982 15 20,842 22 7,088 21 7 (0)
back strongly from every year of
2019 12,168 12 17,103 (4) 5,835 (10) (22) (5) negative/low returns.
2018 10,863 3 17,876 (15) 6,449 (29) (32) (14)
2017 10,531 29 21,134 47 9,093 57 29 10 • In recent times, CY20 performance (up
2016 8,186 3 14,351 7 5,781 2 (1) (5)
21%) came on the back of two years of
double-digit decline i.e. -29% in CY18 and
2015 7,946 (4) 13,397 6 5,653 7 11 1
-10% in CY19.
2014 8,283 31 12,584 56 5,273 55 24 (1)
2013 6,304 7 8,071 (5) 3,403 (8) (15) (3) • There remains significant headroom for
2012 5,905 28 8,505 39 3,710 37 9 (2) continued recovery in the small cap
2011 4,624 (25) 6,112 (31) 2,712 (34) (9) (3) space
2010 6,135 18 8,857 19 4,101 18 (0) (2)
• Interestingly small cap’s are yet to
1.00
Beta (x)
Nifty Small Cap 100 vs. Nifty 50, the present small 0.60
cap index beta stands at ~0.5x i.e. near to average-2
std dev; near to its bottom range. The same is 0.40
indicative of potential outperformance of Small caps 0.20
vis-à-vis bellwether index
CY05
CY07
CY08
CY09
CY10
CY11
CY13
CY14
CY15
CY16
CY18
CY19
CY20
CY06
CY12
CY17
(Small Cap beta = small cap index value/Nifty index Small Cap beta Average small cap beta +2 SD -2 SD
value)
Source:: NSE, ICICI Direct Research
MOMENTUM PICK
35
30
25
20 Low interest rate scenario is a key tailwind to overall equities
YoY Earnings growth (% )
30.2
16.2
26.7
18.4
21.5
28.0
24.2
18.8
27.3
5 to ~24% CAGR seen at large caps and ~19% CAGR seen at mid
9.1
7.1
0 caps
2 year CAGR
FY21E
FY22E
FY23E
(FY21-23E)
Nifty Nifty MidCap 100 Nifty SmallCap 100
15 15.8
17.3 higher expected earnings up ahead, valuations for small caps vis-
10 13.5 a-vis narrower indices are at attractive levels (~14x P/E on FY23E
5 EPS). This provides margin of safety on small caps.
0
FY20
FY21E
FY22E
FY23E
MOMENTUM PICK
1500 12,000
1200 10,000
A leader in supplying carbon black, an 8,000
900
essential compound for manufactruing tyres 6,000
600
4,000
Details Initiation Peak 300 2,000
Date 11-Jul-16 12-Jan-18 0 0
Jan-17
Jan-18
Oct-16
Oct-17
Jul-16
Jul-17
Apr-17
Price 175 1455
Mcap 600 crore 5,000 crore
Phillips Carbon Black (LHS) Nifty Small Cap 100 (RHS)
RoCE 6% 17%
Affle India turned ~3x vs. small cap index return of 75%
Sep-20
Sep-20
Dec-20
Oct-20
Oct-20
Jun-20
Jun-20
Jun-20
May-20
May-20
Jul-20
Jul-20
Nov-20
Nov-20
Nov-20
Aug-20
Aug-20
Price 1275 4007
Mcap 3,250 crore 10,200 crore
Affle India (LHS) Nifty Small Cap 100 (RHS)
RoCE 32% 32%
MOMENTUM PICK
Its key parameters include:
• Capital efficient businesses (subjective) with well defined path of higher return ratios in future. Expansion of sustainable ROCE.
• Dominant market share position
• Robust growth prospects
• Low on debt & leverage
• Sound Financials; healthy B/S, positive cash generating businesses
• Run exhaustive check in terms of management pedigree and other corporate governance parameters
• Time horizon – We believe stocks show reasonable performance over 3-5 years
MOMENTUM PICK
Auto 5.2%
Minda Corporation 93 275 25,575 5.2%
For our small cap portfolio offering, we have chosen businesses that are
Consumer Durable 16.8%
capital efficient, are strong cash generators (all companies CFO positive
Bajaj Electrical 1,022 30 30,660 6.2%
in FY20), possess strong B/S (average debt:equity as of FY20 at ~0.3x)
Amber Enterprises 2,963 10 29,630 6.0%
Huhtamaki India 302 75 22,650 4.6%
Capital Goods 9.6% Diversified industry exposure
Elgi Equipment 170 120 20,400 4.1%
Timken India 1,345 20 26,900 5.5% Portfolio Sectoral Mix
Cement 4.9%
Sagar Cement 688 35 24,080 4.9%
Infrastructure 10.0% 9.5% 5.2%
Brigade Enterprises 286 80 22,880 4.6% 8.8% 16.8%
PNC Infra 264 100 26,400 5.4%
Strong operational performance expected from small cap portfolio in coming years …
MOMENTUM PICK
Net sales are expected to grow at 18.7% CAGR over
75,000 FY21E-23E
For the small cap portfolio, margins are expected to
16.0%
expand from ~12% in FY20 to ~14.5% by FY23E
60,000
₹ crore
14.0%
45,000
30,000 12.0%
%
49,505
60,456
52,445
69,778
15,000 10.0%
11.9%
13.3%
14.3%
14.5%
0 8.0%
FY21E
FY22E
FY23E
FY20
FY21E
FY23E
FY22E
FY20
4,500 20.0%
₹ crore
%
3,000
15.0%
14.5%
17.2%
17.1%
20.0%
18.3%
21.5%
1,500
2,620
4,377
5,345
3,116
10.0%
0
FY21E
FY22E
FY23E
FY22E
FY23E
FY21E
FY20
RoE RoCE
Company View
Minda Corporation (MCL) is a leading auto ancillary player with a history of capital efficient operations, net debt free B/S (September 2020) and presence across
new model launches like Mahindra Thar & Bajaj Chetak. We like MCL primarily on account of; its well-diversified presence across segments with 2-W, CV, PV
MOMENTUM PICK
Minda Corporation and aftermarket constituting ~53%, 23%, 10%, 14% of its sales (FY20), respectively. In the recent past, MCL also took a hard call by letting go its loss making
and capital inefficient European business (Minda KTSN) with its base business i.e. mechatronics and wiring harness largely immune to EV risk. We are also
enthused by MCL’s intent to clock ~12% margins & ~20%+ RoIC, going forward
We like Bajaj Electricals for its strong recovery in H1FY21 performance of electrical consumer durable business. We believe Bajaj Electricals will be among few
fast moving electrical goods (FMEG) players who are going to report 100% sales recovery in FY21 due to strong rural penetration despite sales loss for almost 40
Bajaj Electrical
days in FY21 amid pandemic. Also, the management effort to keep limited exposure in the project business, improved balance sheet condition (D/E at 0.5x) and
strong distribution networks bodes well for stock, going forward
Amber Enterprises is the key supplier to all the top 10 AC brands and commands ~24% volume market share of ACs sold in India during FY20. We see a long
term play in Amber given a significant business opportunity arising through import restrictions on RAC and its components (business opportunity of ~| 10,000
Amber Enterprises
crore) and India’s AC export opportunities (market share may cross | 27,000 crore in the next 10 years from mere | 450 crore in FY19). With revenue, PAT
CAGR of 19%, 26%, respectively, in FY20-23E, we believe the stock is available at attractive valuation (27x earnings of FY21 EPS)
HIL is the leading player in the flexible packaging industry, providing packaging & labelling solutions to its clients through its ~18 plants and two R&D centres
across India. The major client includes Nestlé, HUL, P&G, Mondelez, Coca Cola, etc. A leadership position in the domestic flexible packaging industry, strong
Huhtamaki
client base and focus on launching innovating products will be key drivers of revenue & PAT growth in CY20E-22E. Healthy balance sheet (D/E: 0.4x, RoE:
Overall, Elgi’s strategy to expand in new geographies in Europe, continued growth momentum in the US, Australia and expected rebound in South East Asia &
Gulf markets are expected to contribute significantly to incremental growth in coming years. A rebound was visible in Q2FY21 performance with air compressor
international sales (including exports from India) contributing ~57% to total air compressor sales registering growth of ~39% to | 253 crore YoY. Margins are
Elgi Equipments
expected to improve due to ramp-up in international business, operating cost reduction initiatives to lead incremental revenue, future growth and positive
operating leverage. Going ahead, further traction in the international market, new products like oil free compressors (AB series) would aid growth while green
shoots of revival visible in India business would further aid topline
Timken India is the leading tapered roller bearings manufacturer in India with a strong presence & leadership position in freight segment bearings. Upcoming
thrust on Infrastructure, railways (conversion of conventional coaches to LHB coaches), DFC and upcoming metro projects augur well for the company. Also, a
Timken India
revival in CV and overall auto segment is also expected to provide further fillip. We like the stock due to its MNC brand, high return ratios & a debt free balance
sheet combined with a robust outlook
Sagar Cement is a mid-sized cement player (5.75 MT) with cement plants located in Andhra region. The company has a presence in Andhra Pradesh (34%),
Telangana (25%), Tamil Nadu (12%) and Karnataka (11%), with the company’s brand Sagar Cements being a renowned one in southern India. The company also
has a presence in Maharashtra (9%) and Odisha (8%), thereby being well-diversified in terms of sales flow. The company’s cost of production (CoP) is one of the
Sagar Cement lowest in the south market. In the past three years, the company has also initiated further cost efficiency measures like setting up of coal based CPP of 18 MW
at its plant in Mattampally, Nalgonda and expansion of grinding unit in Bayyavaram to 1.5 MT. The company is aiming to reach 10 MT capacity by FY25E. While
the full benefit of new capacities would start flowing in from FY23E, we expect expansion led revenue CAGR of 20.5% in FY20-22E. Further, strong management
profile, cost efficiency and healthy BS should augur well, going ahead
Company View
The residential segment has displayed a strong recovery and continued momentum is likely to aid overall cash generation. The company is in various stages of
MOMENTUM PICK
Brigade Enterprise discussions to lease 1.4 msf area over the next six months, which will boost its rental revenues. Reopening of economy is likely to boost retail and hospitality
segment, albeit gradually. Brigade has comfortable debt-equity and sufficient liquidity from operational commercial assets (and likely operational assets)
PNC remains our preferred pick in the EPC space given its robust order book, healthy return ratios and lean balance sheet (debt free on standalone).
Notwithstanding its asset monetisation plan fructification, sufficient internal accruals from current order book is enough for equity infusion. The Increased
PNC Infratech
allocation to MoRTH in Union Budget (up 17% YoY at | 1.08 lakh crore) will help in expanding road network as well as higher order inflows opportunity for road
EPC players like PNC
TeamLease Services (TLS) is one of India’s leading providers of human resource services in the organised segment. TLS’ services span the entire human
resources supply chain covering employment, employability and education. Employment services include temporary staffing solutions, IT staffing and regulatory
consultancy for labour law compliance while employability offerings include learning and training solutions. The company is expected to be a key beneficiary of
Teamlease Services
formalisation of the economy. This, coupled with increase in outsourcing, consolidation of market and market share gains are other long term revenue drivers for
the company. In addition, we expect specialised staffing revenues to improve led by a revival in IT services and reducing competitive intensity. Further,
improving cashflows and margins are other key positives. Hence, we have a positive view on the stock
Birlasoft, an IT service company, caters to diverse sectors and geographies. In terms of geographies, Birlasoft generates, 82% from America, 8.7% from Europe
and 9.7% from Rest of the World (RoW). In terms of verticals, the company generates 40.7% from manufacturing, 17.1% from BFSI, 17.0% from energy &
utilities and 25% from life-sciences. Birlasoft has also aligned sales structure across verticals to improve cross selling opportunities, multi service deals and
Company View
Post pandemic, companies are reviewing their supply chains and increasingly looking at Omni-channel presence & B2C models. Specialised 3PL companies in
MOMENTUM PICK
such environments can provide reduced logistics costs, better turnaround time to each client on greater efficiency, lower capex, better utilisation level vs. each
company’s internal logistics operations. MLL continues to expand operations with its existing clients and also acquire new clients, helped by increased
Mahindra Logistics
customer focus on tech backed solutions to their supply chain operations. With a changing client profile (addition of non-auto clients), MLL has been able to
leverage the situation by enhancing high margin warehousing, value-added services component in its revenue mix. MLL has strengthened its already strong
liquidity position on balance sheet and continues to improve its cash conversion cycle
Express logistics continues to remain beneficiary of the normalisation of the business cycle. We expect the company to report a revival in revenue growth
driven by new branch additions & expansion of clients in SME segment. TCI Express is expected to tide over the current volatility by continued automation,
TCI Express enhancing technological capabilities and reducing field footprints. The management’s singular focus on carrying profitable shipments in the B2B segment along
the surface route, has consistently led to stable operational performance, even amid lower volumes scenario (as seen in H1). Low leverage, a robust growth
trajectory and high core return ratios (FY22E RoCE at 28%, healthy FCF yield), position TCIEL as one of the preferred picks in the logistics space
Advanced Enzyme is poised to capture the growing opportunities in the enzymes and probiotics space backed by proven capabilities and stable financials that
have been fairly consistent, thanks to a mix of organic and inorganic growth strategy employed by the management. Strong margins and healthy return ratios
Advanced Enzymes reflect the pricing power and balance sheet strength of the company. Going ahead, the management intends to augment its R&D capability for better facilitation
and strengthening of in-house R&D capability, which bodes well in the long run in its quest to improve scalability and a possible foray into more complex
After going through rough patches in FY18-19, where Indoco faced headwinds on the domestic front (structural issues) and exports front (regulatory setbacks),
the situation is returning to normalcy. While FY21 growth in the domestic market is likely to be impacted amid Covid-19, exports are likely to deliver robust
Indoco Remedies
growth on the back of strong pipeline and visible launch schedule as reflected in the upbeat management guidance. Also, normalisation of exports dispatches is
likely to improve operating leverage as well. With better visibility, we expect the company to maintain consistency and generate strong FCF
The company plans to incur a capex of | 800 crore over the next five to six years. The majority of this capex would go towards building capacity for export
business. This incremental capex can have asset turn of 2-2.5x, providing decent visibility for the topline growth. Further, backward integration capex would aid
Rallis India
gross margins, to a certain level, and thereby translates into better operating visibility. In turn, this can support bottomline performance and return ratios for the
coming future. This should help the company to demand better valuations. Thus, we remain positive on the stock
The company’s operations and demand from end users are reverting back to normal as the economy opens up. The company’s H2 is also likely to benefit amid
some pent-up demand. Amid strong demand, the company is trying to expedite its growth capex plans of | 585 crore (which have been bit delayed amid Covid),
Sudarshan Chemicals which gives a visibility and management commitment towards future growth. Sudarshan’s consistent track record, with favourable macro factors and robust
domestic demand are key catalysts for it. Margins are also likely to improve due to backward integration and change in product mix towards margin accretive
products
ANALYST CERTIFICATION
MOMENTUM PICK
I/We, Pankaj Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our
views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s)
or view(s) in this report. It is also confirmed that above mentioned Analysts of this report have not received any compensation from the companies mentioned in the report in
the preceding twelve months and do not serve as an officer, director or employee of the companies mentioned in the report.
ICICI Securities Limited (ICICI Securities) is a full-service, integrated investment banking and is, inter alia, engaged in the business of stock brokering and distribution of financial
products. ICICI Securities is Sebi registered stock broker, merchant banker, investment adviser, portfolio manager and Research Analyst. ICICI Securities is registered with
Insurance Regulatory Development Authority of India Limited (IRDAI) as a composite corporate agent and with PFRDA as a Point of Presence. ICICI Securities Limited Research
Analyst SEBI Registration Number – INH000000990. ICICI Securities Limited SEBI Registration is INZ000183631 for stock broker. ICICI Securities is a subsidiary of ICICI Bank
which is India’s largest private sector bank and has its various subsidiaries engaged in businesses of housing finance, asset management, life insurance, general insurance,
venture capital fund management, etc. (“associates”), the details in respect of which are available on www.icicibank.com.
ICICI Securities is one of the leading merchant bankers/ underwriters of securities and participate in virtually all securities trading markets in India. We and our associates might
have investment banking and other business relationship with a significant percentage of companies covered by our Investment Research Department. ICICI Securities
generally prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or derivatives of any companies that the
analysts cover
Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein.
ICICI Securities Limited has two independent equity research groups: Institutional Research and Retail Research. This report has been prepared by the Retail Research. The
views and opinions expressed in this document may or may not match or may be contrary with the views, estimates, rating, and target price of the Institutional Research.
The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained herein is
strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person
or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would endeavour to update the information herein on a reasonable basis,
ICICI Securities is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent ICICI Securities
from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable
regulations and/or ICICI Securities policies, in circumstances where ICICI Securities might be acting in an advisory capacity to this company, or in certain other circumstances.
23
Disclaimer
This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or
completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of
MOMENTUM PICK
offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this
report at the same time. ICICI Securities will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal,
accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions
expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions
and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate
the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. ICICI Securities accepts
no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors
are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set
forth in projections. Forward-looking statements are not predictions and may be subject to change without notice.
ICICI Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject
company for any other assignment in the past twelve months.
ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the
date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or
other advisory service in a merger or specific transaction.
ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its associates
or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research
report. Accordingly, neither ICICI Securities nor Research Analysts and their relatives have any material conflict of interest at the time of publication of this report.
24